Cumulative Corticosteroid Doses and Osteoporosis in Patients with Multiple Sclerosis

Arslan Ş., Celiker R., KARABUDAK R.

TURKISH JOURNAL OF RHEUMATOLOGY, cilt.25, sa.4, ss.191-195, 2010 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 4
  • Basım Tarihi: 2010
  • Doi Numarası: 10.5152/tjr.2010.27
  • Dergi Adı: TURKISH JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.191-195
  • Anahtar Kelimeler: Bone mineral density, corticosteroids, multiple sclerosis, osteoporosis, GLUCOCORTICOID-INDUCED OSTEOPOROSIS, SECONDARY OSTEOPOROSIS, BONE LOSS, METHYLPREDNISOLONE, PATHOGENESIS, PREVENTION, THERAPY, PULSES
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Objective: Multiple sclerosis (MS) is an inflammatory demyelinating disorder and corticosteroids used for the treatment of attacks are known to cause osteoporosis. Although osteoporosis is a known potential complication, many patients do not receive treatment to prevent bone loss. The aim of this study was to assess the relationship between cumulative doses of corticosteroids and bone mineral density (BMD) in MS patients.